Knockdown of YAP1 Reduces YTHDF3 to Stabilize SMAD7 and thus Inhibit Bladder Cancer Stem Cell Stemness
Dandan Qiu1, Lingling Gao2, Xingwei Yu1
1Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 310000 Hangzhou, Zhejiang, China.
Background:
The previous study has proved the oncogenic role of Yes-associated protein 1 (YAP1) in bladder cancer (BLCA), thus this study focused on its impact on bladder cancer stem cells (BCSCs) and underlying mechanism.
Method:
BCSCs were obtained by treating human BLCA cells UMUC3 with cisplatin and identified by measuring CD133+ in UMUC3/BCSCs via flow cytometry. YAP1 interaction proteins and mothers against decapentaplegic homolog 7 (SMAD7) N6-methyladenosine (m6A) site were analyzed by bioinformatics. BCSCs were transfected. SMAD7 m6A level, YTH domain-containing family proteins 3 (YTHDF3)-SMAD7 interaction, YAP1/YTHDF3 expression in BCSCs were assessed by methylated RNA immunoprecipitation (MeRIP), RNA immunoprecipitation (RIP) or quantitative reverse transcription PCR (qRT-PCR), respectively. BCSC proliferation was detected by 5-Bromo-2-deoxyuridine (BrdU) staining. UMUC3/BCSC migration/invasion and tumour sphere formation were determined by Transwell or tumour sphere formation assays. YAP1/YTHDF3/SMAD7/transforming growth factor (TGF)-β1/stemness marker expressions in UMUC3/BCSCs were measured by Western blot assay.
Result:
BCSCs showed higher CD133+ ratio, expressions of stemness marker/YAP1/YTHDF3/TGF-β1, lower SMAD7 expression and greater invasion/migration/tumour sphere formation capabilities than UMUC3 cells. YAP1 knockdown decreased SMAD7 m6A level and impaired YTHDF3-SMAD7 interaction in BCSCs. YAP1 silencing inhibited cell growth/invasiveness/migration/tumour sphere formation and stemness-associated protein/YTHDF3/TGF-β1 expressions while upregulating SMAD7 expression in BCSCs, which was offset by YTHDF3 overexpression.
Conclusion:
The silencing of YAP1 in BCSCs impedes the YTHDF3-mediated degradation of m6A-modified SMAD7, culminating in diminished cell stemness.
Insights
Yes-associated protein 1 (YAP1) silencing in bladder cancer stem cells (BCSCs) inhibits YTH domain-containing family protein 3 (YTHDF3)-mediated degradation of m6A-modified SMAD7. This leads to reduced cell stemness and tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Previous studies established the oncogenic role of Yes-associated protein 1 (YAP1) in bladder cancer (BLCA).
- This research investigates YAP1's specific impact on bladder cancer stem cells (BCSCs) and its underlying molecular mechanisms.
Purpose of the Study:
- To elucidate the role of YAP1 in regulating the stemness and progression of bladder cancer stem cells (BCSCs).
- To identify the molecular pathways, including N6-methyladenosine (m6A) modification and protein interactions, involved in YAP1's function in BCSCs.
Main Methods:
- Bladder cancer stem cells (BCSCs) were isolated and characterized by CD133 expression.
- Bioinformatic analysis identified YAP1 interacting proteins and the m6A site on SMAD7.
- Experiments involved gene silencing (YAP1), overexpression (YTHDF3), and molecular assays (MeRIP, RIP, qRT-PCR, Western blot) to assess gene expression, protein interactions, and m6A modification levels.
- Functional assays included proliferation (BrdU), migration/invasion (Transwell), and tumor sphere formation assays.
Main Results:
- BCSCs exhibited higher stemness markers, YAP1, YTHDF3, TGF-β1 expression, and enhanced invasive capabilities compared to parental BLCA cells, with lower SMAD7 expression.
- YAP1 knockdown reduced SMAD7 m6A levels and YTHDF3-SMAD7 interaction.
- Silencing YAP1 inhibited BCSC proliferation, migration, invasion, and tumor sphere formation, while increasing SMAD7 expression. This effect was reversed by YTHDF3 overexpression.
Conclusions:
- YAP1 plays a crucial role in maintaining bladder cancer stemness.
- YAP1 silencing disrupts the YTHDF3-mediated degradation of m6A-modified SMAD7, thereby reducing BCSCs stemness and potential for tumor progression.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
